170 related articles for article (PubMed ID: 31154410)
21. The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population.
Nordborg C; Johansson H; Petursdottir V; Nordborg E
Rheumatology (Oxford); 2003 Apr; 42(4):549-52. PubMed ID: 12649402
[TBL] [Abstract][Full Text] [Related]
22. Risk of Cancer in 767 Patients with Giant Cell Arteritis in Western Norway: A Retrospective Cohort with Matched Controls.
Brekke LK; Fevang BS; Diamantopoulos AP; Assmus J; Esperø E; Gjesdal CG
J Rheumatol; 2020 May; 47(5):722-729. PubMed ID: 31308209
[TBL] [Abstract][Full Text] [Related]
23. Seasonal variation in biopsy-proven giant cell arteritis in Eastern Denmark from 1990-2018.
Kønig EB; Stormly Hansen M; Foldager J; Siersma V; Loft A; Terslev L; Møller Døhn U; Radmer Jensen M; Wiencke AK; Faber C; Hamann S; Heegaard S
Acta Ophthalmol; 2021 Aug; 99(5):527-532. PubMed ID: 33211398
[TBL] [Abstract][Full Text] [Related]
24. Cancer preceding giant cell arteritis: a case-control study.
Kermani TA; Schäfer VS; Crowson CS; Hunder GG; Ytterberg SR; Matteson EL; Gabriel SE; Warrington KJ
Arthritis Rheum; 2010 Jun; 62(6):1763-9. PubMed ID: 20191583
[TBL] [Abstract][Full Text] [Related]
25. Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study.
Muratore F; Boiardi L; Mancuso P; Restuccia G; Galli E; Marvisi C; Macchioni P; Rossi PG; Salvarani C
Semin Arthritis Rheum; 2021 Aug; 51(4):786-792. PubMed ID: 34148007
[TBL] [Abstract][Full Text] [Related]
26. Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden.
Ji J; Dimitrijevic I; Sundquist J; Sundquist K; Zöller B
Scand J Rheumatol; 2017 Nov; 46(6):484-489. PubMed ID: 28276953
[TBL] [Abstract][Full Text] [Related]
27. Reappraisal of large artery involvement in giant cell arteritis: a population-based cohort over 70 years.
Elfishawi MM; Kaymakci MS; J Achenbach S; S Crowson C; Kermani TA; M Weyand C; J Koster M; Warrington KJ
RMD Open; 2024 Feb; 10(1):. PubMed ID: 38331471
[TBL] [Abstract][Full Text] [Related]
28. Influence of age, sex, and place of residence on clinical expression of giant cell arteritis in northwest Spain.
Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J
J Rheumatol; 2003 Jul; 30(7):1548-51. PubMed ID: 12858456
[TBL] [Abstract][Full Text] [Related]
29. Stroke associated with giant cell arteritis: a population-based study.
Samson M; Jacquin A; Audia S; Daubail B; Devilliers H; Petrella T; Martin L; Durier J; Besancenot JF; Lorcerie B; Giroud M; Bonnotte B; Béjot Y
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):216-21. PubMed ID: 24780954
[TBL] [Abstract][Full Text] [Related]
30. Incidence Trends and Mortality of Giant Cell Arteritis in Southern Norway.
Andersen JB; Myklebust G; Haugeberg G; Pripp AH; Diamantopoulos AP
Arthritis Care Res (Hoboken); 2021 Mar; 73(3):409-414. PubMed ID: 31909871
[TBL] [Abstract][Full Text] [Related]
31. Giant cell arteritis: A nationwide, population-based cohort study on incidence, diagnostic imaging, and glucocorticoid treatment.
Therkildsen P; de Thurah A; Hansen IT; Nørgaard M; Nielsen BD; Hauge EM
Semin Arthritis Rheum; 2021 Apr; 51(2):360-366. PubMed ID: 33601192
[TBL] [Abstract][Full Text] [Related]
32. Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy.
Grossman C; Barshack I; Koren-Morag N; Ben-Zvi I; Bornstein G
Clin Rheumatol; 2016 Jul; 35(7):1817-22. PubMed ID: 26925851
[TBL] [Abstract][Full Text] [Related]
33. A nationwide study of ocular manifestations leading to hospital contacts among patients with giant cell arteritis.
Therkildsen P; de Thurah A; Faurschou M; Baslund B; Hansen IT; Nørgaard M; Nielsen BD; Hauge EM
Semin Arthritis Rheum; 2022 Oct; 56():152071. PubMed ID: 35878473
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis: a population-based case-control study.
Turkiewicz A; Stamatis P; Mohammad AJ
RMD Open; 2020 Aug; 6(2):. PubMed ID: 32792416
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Performance of a Temporal Artery Biopsy for the Diagnosis of Giant Cell Arteritis in Japan-A Single-center Retrospective Cohort Study.
Oiwa H; Ichimura K; Hosokawa Y; Araki K; Funaki M; Kawashima M; Mihara H; Kimura N
Intern Med; 2019 Sep; 58(17):2451-2458. PubMed ID: 31118402
[TBL] [Abstract][Full Text] [Related]
36. Negative temporal artery biopsy: predictive factors for giant cell arteritis diagnosis and alternate diagnoses of patients without arteritis.
Bornstein G; Barshack I; Koren-Morag N; Ben-Zvi I; Furie N; Grossman C
Clin Rheumatol; 2018 Oct; 37(10):2819-2824. PubMed ID: 29549493
[TBL] [Abstract][Full Text] [Related]
37. Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study.
Muratore F; Cavazza A; Boiardi L; Lo Gullo A; Pipitone N; Germanò G; Bisagni A; Cimino L; Salvarani C
Arthritis Care Res (Hoboken); 2016 Jun; 68(6):865-70. PubMed ID: 26415044
[TBL] [Abstract][Full Text] [Related]
38. Giant cell arteritis and mortality.
Crow RW; Katz BJ; Warner JE; Alder SC; Zhang K; Schulman S; Digre KB
J Gerontol A Biol Sci Med Sci; 2009 Mar; 64(3):365-9. PubMed ID: 19196636
[TBL] [Abstract][Full Text] [Related]
39. The incidence of giant cell arteritis in Slovenia.
Pucelj NP; Hočevar A; Ješe R; Rotar Ž; Hawlina M; Fakin A; Pižem J; Tomšič M
Clin Rheumatol; 2019 Feb; 38(2):285-290. PubMed ID: 30062445
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular risk factors and incident giant cell arteritis: a population-based cohort study.
Tomasson G; Bjornsson J; Zhang Y; Gudnason V; Merkel PA
Scand J Rheumatol; 2019 May; 48(3):213-217. PubMed ID: 30460876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
